logo

For the Inventor, By the Inventor

Plano, TX, United States of America

Eric J Hansen

This inventor holds 16 USPTO granted patents and 1 EPO patent. Top assignees: The University of Texas System, Wyeth Holdings Corporation, American Cyanamid Company. Active years: 1984-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric J Hansen. Retrieved from https://idiyas.com/inventor/eric-j-hansen-b03xozro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 68.8


Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 65(Granted Patents)


Company Filing History:

goldMedal13 out of 5,638 
 
The University of Texas System
 patents
silverMedal2 out of 113 
 
Wyeth Holdings Corporation
 patents
bronzeMedal1 out of 3,580 
 
American Cyanamid Company
 patents
4. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2009

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 7576194 - UspA2 nucleic acid of moraxella catarrhalis (2009-08-18),
2. 7569683 - [object Object] (2009-08-04),
3. 7344724 - [object Object] (2008-03-18),
4. 7288646 - [object Object] (2007-10-30),
5. 6753417 - UspA1 and UspA2 antigens of Moraxella catarrhalis (2004-06-22),
6. 6310190 - USPA1 and USPA2 antigens of Moraxella catarrhalis (2001-10-30),
7. 6020154 - H. influenzae HxuB and HxuC genes, proteins and methods of use (2000-02-01),
8. 5993826 - Methods and compositions relating to useful antigens of moraxella (1999-11-30),
9. 5981213 - Methods and compositions relating to useful antigens of moraxella (1999-11-09),
10. 5759813 - Methods and compositions relating to useful antigens of moraxella (1998-06-02),
11. 5599693 - Methods and compositions relating to useful antigens of moraxella (1997-02-04),
12. 5552146 - Methods and compositions relating to useful antigens of Moraxella (1996-09-03),
13. 5380655 - Methods and compositions for the production of haemophilus influenzae (1995-01-10),
14. 5356778 - Method for detection of gram-negative bacterial liposaccharides in (1994-10-18),
15. 5198339 - Method for detection of gram-negative bacterial lipopolysaccharides in (1993-03-30),

Title: Eric J Hansen: Innovator in Molecular Biology

Introduction

Eric J Hansen is a notable inventor based in Plano, TX (US). He has made significant contributions to the field of molecular biology, particularly through his research on novel proteins. With a total of 16 patents to his name, Hansen's work has had a considerable impact on diagnostics and therapeutic methods.

Latest Patents

One of Hansen's latest patents involves the UspA2 nucleic acid of Moraxella catarrhalis. This invention discloses the existence of two novel proteins, UspA1 and UspA2, along with their respective genes, uspA1 and uspA2. Each protein contains a conserved region and an epitope recognized by the MAb 17C7. These proteins may aggregate to form a very high molecular weight form of the UspA antigen, which is greater than 200 kDa. The patent also includes compositions and methods for both diagnostic and therapeutic applications.

Career Highlights

Hansen has worked with the University of Texas System, where he has contributed to various research initiatives. His innovative work has led to advancements in understanding and treating diseases associated with Moraxella catarrhalis.

Collaborations

Some of Hansen's notable coworkers include Isobel Maciver and Leslie D Cope. Their collaborative efforts have furthered research in molecular biology and related fields.

Conclusion

Eric J Hansen is a distinguished inventor whose work in molecular biology has led to significant advancements in the understanding of novel proteins. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…